kabutan

CellSource Co., Ltd.(4880) Summary

4880
TSE Prime
CellSource Co., Ltd.
483
JPY
-1
(-0.21%)
Dec 5, 11:30 am JST
3.11
USD
Dec 4, 9:30 pm EST
Result
PTS
outside of trading hours
482.1
Dec 5, 10:47 am JST
Summary Chart Historical News Financial Result
PER
85.4
PBR
1.60
Yield
1.04%
Margin Trading Ratio
27.13
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
481 JPY 3.10 USD
Previous Close Dec 4
484 JPY 3.11 USD
High Dec 5, 9:24 am
485 JPY 3.12 USD
Low Dec 5, 9:05 am
480 JPY 3.09 USD
Volume
19,100
Trading Value
9.00M JPY 0.06M USD
VWAP
483.08 JPY 3.12 USD
Minimum Trading Value
48,300 JPY 311 USD
Market Cap
9.57B JPY 0.06B USD
Number of Trades
44
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
214
1-Year High Dec 12, 2024
1,415
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 85,800 439,900 5.13
Nov 21, 2025 87,800 446,200 5.08
Nov 14, 2025 105,000 457,800 4.36
Nov 7, 2025 95,000 466,300 4.91
Oct 31, 2025 92,500 451,200 4.88
Company Profile
CellSource Co., Ltd. develops and sells regenerative medicine-related products and cosmetics, specializing in cell processing from fat and blood.
Sector
Pharmaceuticals
CellSource Co., Ltd. primarily focuses on regenerative medicine-related businesses, providing cell processing and storage services from blood and fat for medical institutions. The company operates facilities licensed for manufacturing specific cell products under the Act on the Safety of Regenerative Medicine, where they extract, culture, and cryopreserve adipose-derived stem cells. Additionally, CellSource offers consulting services for regulatory compliance and management support necessary for providing regenerative medicine, as well as sales of related medical equipment. Furthermore, the company manufactures and sells its own cosmetics brand "Signalift," which incorporates proprietary ingredients derived from adipose stem cell research. CellSource also supplies cosmetic raw materials and provides OEM manufacturing services.